Honkamp Krueger Financial Services »

Xilio Therapeutics shares owned by Honkamp Krueger Financial Services

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Honkamp Krueger Financial Services from 13F filings

Historical chart of Honkamp Krueger Financial Services investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Honkamp Krueger Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Honkamp Krueger Financial Services

Quarter filed Position value Share count Share price at filing
2024-06-30 $24k 25k 0.95

More positions owned by Honkamp Krueger Financial Services

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Spdr Ser Tr Portfolio Ln Tsr (SPTL)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Spdr Ser Tr Nuveen Bloomberg (HYMB)
Spdr Index Shs Fds Msci Acwi Exus (CWI)
First Tr Exchange-traded Managd Mun Etf (FMB)
Apple (AAPL)
Vanguard Specialized Funds Div App Etf (VIG)
Alps Etf Tr Intl Sec Dv Dog (IDOG)
Ishares Tr National Mun Etf (MUB)
Spdr Ser Tr S&P 600 SMCP GRW (SLYG)

View all positions for Honkamp Krueger Financial Services

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
Rock Springs Capital Management
RiverVest Venture Management
Morgan Stanley
Vanguard Group
Renaissance Technologies
Balyasny Asset Management
Geode Capital Management
Bridgeway Capital Management
BlackRock
State Street Corporation
SevenBridge Financial
Raymond James & Associates
XTX Topco
Honkamp Krueger Financial Services

View all funds holding Xilio Therapeutics